Lincoln Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024, to consider and approve un-audited financial results (standalone and consolidated) of the Company for the quarter and half year ended on September 30, 2024.
The above information is a part of company’s filings submitted to BSE.